PlexBio Company Description

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects.

It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets.

PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.

PlexBio Co., Ltd.

Country	Taiwan
Founded	2009
Industry	Medical Instruments & Supplies
Sector	Healthcare
CEO	Ting Cao

Contact Details

Address: No. 351, Yangguang Street Taipei, 11491 Taiwan
Phone	886 2 2627 5878
Website	plexbio.com

Stock Details

Ticker Symbol	6572
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006572001
SIC Code	2835

Key Executives

Name	Position
Ting Cao	Chief Executive Officer
Lipi Yeh	Chief Financial Officer
Erik Hsu	Chief Operating Officer